Insulin glargine/lixisenatide
(Redirected from Soliqua)
Insulin glargine/lixisenatide is a combination medication used in the treatment of Type 2 diabetes. It is a combination of insulin glargine, a long-acting insulin, and lixisenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist.
Composition[edit | edit source]
The medication is composed of two active ingredients: insulin glargine and lixisenatide. Insulin glargine is a long-acting insulin analog that helps to control blood sugar levels in individuals with diabetes. Lixisenatide is a GLP-1 receptor agonist that slows gastric emptying and increases insulin secretion.
Uses[edit | edit source]
Insulin glargine/lixisenatide is used to improve blood sugar control in adults with Type 2 diabetes. It is used when diet and exercise alone does not provide adequate blood sugar control.
Side Effects[edit | edit source]
Common side effects of insulin glargine/lixisenatide include hypoglycemia, allergic reactions, injection site reactions, and gastrointestinal problems. Severe side effects may include pancreatitis and heart failure.
Precautions[edit | edit source]
Before starting treatment with insulin glargine/lixisenatide, patients should inform their healthcare provider about all their medical conditions and medications. It is not recommended for use in patients with Type 1 diabetes or for the treatment of diabetic ketoacidosis.
Interactions[edit | edit source]
Insulin glargine/lixisenatide may interact with other medications, which can affect how it works or increase the risk of serious side effects. Patients should inform their healthcare provider about all the medications they are currently taking.
Dosage[edit | edit source]
The dosage of insulin glargine/lixisenatide is individualized based on the patient's blood sugar control, response to therapy, and other medical conditions.
Storage[edit | edit source]
Insulin glargine/lixisenatide should be stored in the refrigerator, away from light and heat. It should not be frozen.
See Also[edit | edit source]
| Insulin glargine/lixisenatide Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
